In an Australian first development, Sony Foundation has partnered with Australian cancer research charity, Tour de Cure, to grant $500,000 to a qualified cancer research organisation that has an innovative approach to applying Virtual Reality technology in the area of cancer research. Their idea will deliver insightful research with a view to discover ground-breaking and translatable outcomes to assist young cancer patients.

Virtual Reality has already made the impossible, possible. The immersive technology is in active use around the medical world on projects that make a difference, such as helping the blind see, managing chronic pain and enabling scientists to walk around inside cancer cells to investigate their projects at a much deeper level than ever before.

However, this truly unique research grant will require the close collaboration of traditional cancer research organisations with virtual reality content creators from the technology and interactive media industry to take the application of VR beyond pain management and distraction techniques and into a completely new realm.

Possible areas of research to include, but are not limited to:

  • assistance in the understanding and diagnosis of underlying cancer pathologies
  • assistance in the treatment of cancer
  • enhancement of treatment compliance
  • assistance with pain management; rehabilitation
  • enhancement in the provision of survivorship strategies
  • education of young people with respect to cancer prevention strategies
  • other applications outside of these examples will be considered provided they relate to cancer research

The Project will enable cancer research organisations to collaborate with Sony Interactive Entertainment VR developer partners from around the world.


For further information on the Sony Foundation VR Cancer Research Project including criteria, application process and to lodge an application for the grant, please click HERE


Key Dates:

Applications open: Monday, July 2, 2018

Closing Date: Close of Business, Friday, September 28, 2018

Announcement Date: Thursday, November 15, 2018